VERA

Vera Therapeutics, Inc. Class A Common Stock

35.05

USD

+1.45

+4.32%

Sep 11, 15:59 UTC -4

Closed

After-Market

34.80

-0.25

-0.70%

VERA Earnings Reports

Positive Surprise Ratio

VERA beat 7 of 22 last estimates.

32%

Next Report

Date of Next Report

Nov 03, 2026

Estimate for Q3 26 (Revenue/ EPS)

$6.41M

-$1.57

Implied change from Q2 26 (Revenue/ EPS)

+3.29%

Implied change from Q3 25 (Revenue/ EPS)

+24.60%

Vera Therapeutics, Inc. Class A Common Stock earnings per share and revenue

On Aug 10, 2026, VERA reported earnings of -1.52 USD per share (EPS) for Q2 26, beating the estimate of -1.60 USD, resulting in a 5.47% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.08% price change (close before vs. close after earnings).

Looking ahead to Q3 26, -- analysts forecast an EPS of -1.57 USD, with revenue projected to reach 6.41 million USD, implying an increase of 3.29% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Vera Therapeutics, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Vera Therapeutics, Inc. Class A Common Stock reported EPS of -$1.52, beating estimates by 5.47%, and revenue of $0.00, 0% as expectations.

How did the market react to Vera Therapeutics, Inc. Class A Common Stock's Q2 2026 earnings?

The stock price moved down -4.08%, changed from $31.58 before the earnings release to $30.29 the day after.

When is Vera Therapeutics, Inc. Class A Common Stock expected to report next?

The next earning report is scheduled for Nov 03, 2026.

What are the forecasts for Vera Therapeutics, Inc. Class A Common Stock's next earnings report?

Based on -- analysts, Vera Therapeutics, Inc. Class A Common Stock is expected to report EPS of -$1.57 and revenue of $6.41M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.